标题
Switchable immune modulator for tumor-specific activation of anticancer immunity
作者
关键词
-
出版物
Science Advances
Volume 7, Issue 37, Pages -
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2021-09-11
DOI
10.1126/sciadv.abg7291
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Probody therapeutic design of 89Zr-CX-072 promotes accumulation in PD-L1 expressing tumors compared to normal murine lymphoid tissue
- (2020) Danique Giesen et al. CLINICAL CANCER RESEARCH
- Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody
- (2020) Martina Geiger et al. Nature Communications
- An Update on Anti-CD137 Antibodies in Immunotherapies for Cancer
- (2019) Dinh-Toi Chu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A coiled-coil masking domain for selective activation of therapeutic antibodies
- (2019) Vivian H. Trang et al. NATURE BIOTECHNOLOGY
- Targeted antibody and cytokine cancer immunotherapies through collagen affinity
- (2019) Jun Ishihara et al. Science Translational Medicine
- Intratumoral fate of functional nanoparticles in response to microenvironment factor: Implications on cancer diagnosis and therapy
- (2019) Jinrong Peng et al. ADVANCED DRUG DELIVERY REVIEWS
- Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy
- (2019) Noor Momin et al. Science Translational Medicine
- Probody Therapeutics: An Emerging Class of Therapies Designed to Enhance On-Target Effects with Reduced Off-Tumor Toxicity for Use in Immuno-Oncology
- (2019) Karen A. Autio et al. CLINICAL CANCER RESEARCH
- Hypoxia-Activated PEGylated Conditional Aptamer/Antibody for Cancer Imaging with Improved Specificity
- (2019) Fang Zhou et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Programmable Bivalent Peptide–DNA Locks for pH-Based Control of Antibody Activity
- (2019) Wouter Engelen et al. ACS Central Science
- Immune Responses in the Liver
- (2018) Paul Kubes et al. Annual Review of Immunology
- CD8 + T cells and IFN-γ induce autoimmune myelofibrosis in mice
- (2018) Yuan Yao et al. JOURNAL OF AUTOIMMUNITY
- Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury
- (2018) Yoh Zen et al. MODERN PATHOLOGY
- Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
- (2018) Li Tang et al. NATURE BIOTECHNOLOGY
- Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases
- (2018) Chun Gwon Park et al. Science Translational Medicine
- MMP-Responsive ‘Smart’ Drug Delivery and Tumor Targeting
- (2018) Qing Yao et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1–Specific VHHs
- (2018) Michael Dougan et al. Cancer Immunology Research
- Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine
- (2018) Jin-Zhi Du et al. ACCOUNTS OF CHEMICAL RESEARCH
- Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity
- (2018) Chien-Chun Steven Pai et al. JOURNAL OF CLINICAL INVESTIGATION
- In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
- (2018) Qian Chen et al. Nature Nanotechnology
- Selective antibody activation through protease-activated pro-antibodies that mask binding sites with inhibitory domains
- (2017) I-Ju Chen et al. Scientific Reports
- Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody
- (2016) Neil H. Segal et al. CLINICAL CANCER RESEARCH
- Rationale for anti-CD137 cancer immunotherapy
- (2016) Amani Makkouk et al. EUROPEAN JOURNAL OF CANCER
- Preclinical studies of a Pro-antibody-drug conjugate designed to selectively target EGFR-overexpressing tumors with improved therapeutic efficacy
- (2016) Yun Yang et al. mAbs
- Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2
- (2015) Eric F. Zhu et al. CANCER CELL
- Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
- (2015) L. Zhang et al. CLINICAL CANCER RESEARCH
- Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
- (2015) Kevin C. Conlon et al. JOURNAL OF CLINICAL ONCOLOGY
- IL-15 Superagonist–Mediated Immunotoxicity: Role of NK Cells and IFN-γ
- (2015) Yin Guo et al. JOURNAL OF IMMUNOLOGY
- A new prodrug form of Affibody molecules (pro-Affibody) is selectively activated by cancer-associated proteases
- (2014) Lisa Sandersjöö et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Side Effects of Cytokines Approved for Therapy
- (2014) Brian A. Baldo DRUG SAFETY
- Combination of 4-1BB Agonist and PD-1 Antagonist Promotes Antitumor Effector/Memory CD8 T Cells in a Poorly Immunogenic Tumor Model
- (2014) S. Chen et al. Cancer Immunology Research
- Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
- (2013) B. Kwong et al. CANCER RESEARCH
- Tumor-Specific Activation of an EGFR-Targeting Probody Enhances Therapeutic Index
- (2013) L. R. Desnoyers et al. Science Translational Medicine
- Continuous 4–1BB co-stimulatory signals for the optimal expansion of tumor-infiltrating lymphocytes for adoptive T-cell therapy
- (2013) Jessica Ann Chacon et al. OncoImmunology
- The First Generation of β-Galactosidase-Responsive Prodrugs Designed for the Selective Treatment of Solid Tumors in Prodrug Monotherapy
- (2012) Thibaut Legigan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Photocontrolled Targeted Drug Delivery: Photocaged Biologically Active Folic Acid as a Light-Responsive Tumor-Targeting Molecule
- (2012) Nien-Chu Fan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Site-specific targeting of antibody activity in vivo mediated by disease-associated proteases
- (2012) Oran Erster et al. JOURNAL OF CONTROLLED RELEASE
- Acid-Labile Traceless Click Linker for Protein Transduction
- (2012) Kevin Maier et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Immunotherapy of Cancer with 4-1BB
- (2012) D. S. Vinay et al. MOLECULAR CANCER THERAPEUTICS
- Hydrogen Peroxide Activated Matrix Metalloproteinase Inhibitors: A Prodrug Approach
- (2010) Jody L. Major Jourden et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Fast stable restricted maximum likelihood and marginal likelihood estimation of semiparametric generalized linear models
- (2010) Simon N. Wood JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY
- Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
- (2009) M. Ahmadzadeh et al. BLOOD
- Proligands with protease-regulated binding activity identified from cell-displayed prodomain libraries
- (2009) Jerry M. Thomas et al. PROTEIN SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now